Alibaba to pay $600m to settle illegal drug sales allegations in US probe

E-commerce elephantine admitted it failed to ⁠prevent astir 80,000 amerciable cause merchandise sales, according to US Justice Department.

Chinese exertion and e-commerce elephantine Alibaba and its United States-based ⁠payment processor volition wage $600m to resoluteness allegations that they failed to forestall amerciable cause sales, according to the US Justice Department.

The Justice Department said connected Wednesday that Alibaba and AUS Merchant Services agreed arsenic portion of the woody to judge work for the acts of their officers and employees, and heighten their compliance programmes.

Recommended Stories

• list 1 of 3US lists China’s BYD, Alibaba, Baidu arsenic ‘Chinese subject companies’
• list 2 of 3NBA signs AI woody with Alibaba up of preseason games successful China
• list 3 of 3Alibaba sues US subject implicit labelling it a ‘Chinese subject company’

The companies entered into ⁠non-prosecution agreements to resoluteness allegations that they violated the US Federal Food, Drug, and Cosmetic Act by failing to forestall merchants from selling and importing amerciable drugs, chemicals and pill presses into the US done Alibaba’s e-commerce platforms.

“This colony reflects a thorough regulatory process with Alibaba’s afloat practice and our committedness to best-in-class standards of control, policies, and measures against non-compliant merchandise sales,” Alibaba said successful a statement.

According to the Justice Department, Alibaba, arsenic portion of ⁠the deal, admitted that it failed from 2016 to 2024 to ⁠prevent astir 80,000 merchandise income of chemicals, drugs and pharmaceutical counterfeiting instrumentality that were imported from overseas.

Those transactions had a combined merchandise worth of much than $200m, according to the Justice Department.

Law enforcement during ⁠the probe conducted much than 40 undercover purchases of amerciable pharmaceuticals and counterfeiting equipment, it said.

At times, Alibaba employees raised concerns ⁠about whether amerciable products were being sold and whether ⁠the company’s compliance measures were inadequate and could forestall specified income from occurring, the section said.

Law enforcement officers from aggregate US authorities agencies conducted much than 40 undercover purchases of pharmaceuticals and instrumentality that were amerciable to import into the US, according to a quality merchandise connected the colony resolution.

The US authorities said the US-based outgo processor’s anti-money laundering compliance programme failed to forestall immoderate merchants from utilizing its services to ‌facilitate the merchantability and importation of banned products.

“Today’s solution reflects the Department of Justice’s committedness to ensuring that companies operating e-commerce and integer outgo platforms support illegal, unapproved, misbranded, and ‌dangerous ‌foreign pharmaceuticals disconnected their marketplaces,” Assistant US Attorney General Brett Shumate said successful a statement.

Alibaba operates immoderate of the world’s largest e-commerce platforms, including Alibaba.com and AliExpress.com.